Entero Therapeutics is a clinical stage biopharmaceutical company specializing in the development of targeted, orally delivered therapies for gastrointestinal (GI) diseases.
peer of
Metrics
marketPRIVATE
msh_idCOM:AZURRX
localeus
websitehttps://azurrx.com/
source_refacc38992-0358-4e44-bb9f-8b8033c430ef
products_or_servicesLatiglutenase, Capeserod, Adrulipase, and other targeted therapies for gastrointestinal diseases.
United States